Search

everythinglearnresearchcommunity

for

Search:↓

ISCK03 stops melanin production in human melanoma cells and lightens skin color in mice and guinea pigs.

Danthron from Rhubarb causes melanoma cells to stop growing and die.

Baricitinib helps regrow hair in severe alopecia areata and is safe, but more research is needed.

Tofacitinib effectively treated severe hair loss in a patient who didn't respond to other treatments.

New therapies for Birt–Hogg–Dubé syndrome are being developed based on understanding the FLCN gene's role.

Crisaborole may help regrow hair in children with alopecia areata.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

Targeting TCR-Vβ2 in cutaneous T cell lymphoma shows promise for safer, more specific treatment.

Patients prefer the higher 50 mg dose of ritlecitinib for better hair regrowth despite higher risks.

Blocking mTORC1 reduces skin tumor growth in mice.

Cancer treatments can cause various eye problems, so eye doctors should know how to diagnose and treat these early.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

JAK inhibitors are effective for long-term management of alopecia areata.

JAK inhibitors are a promising new treatment for hair loss and nail problems in alopecia areata.

JAK inhibitors effectively treat severe atopic dermatitis and alopecia areata.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.

Upadacitinib improved both Crohn's ileitis and alopecia universalis in a patient.

Combining UVB irradiation and anti-CD154 antibody improves hair follicle transplant survival.

The new platinum complexes effectively increased survival in rats with tumors, despite some reversible side effects.

Tofacitinib may be safe and effective for treating certain skin conditions in children.

Baricitinib significantly regrows hair in teens with severe alopecia areata.

New butyric acid prodrugs show promise for cancer treatment, anemia management, and protecting hair from chemotherapy damage.

Ritlecitinib can reduce inflammation and help hair regrow in Alopecia Areata.

3D imaging effectively tracks skin changes in vitiligo treatment.

JAK inhibitors may become the first approved treatment for alopecia areata if they are proven safe and effective.

Antiviral drugs, especially daclatasvir, may be a new treatment for a rare skin disease, improving survival and reducing symptoms in mice.

Ritlecitinib is effective and safe for long-term treatment of alopecia areata.

Dutasteride may help reduce brain inflammation and improve cognition.